← Product Code [KRB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/KRB) · K020587 # PULSION PULSIOCATH PICCO MONITORING KIT, INJECTATE SENSOR TEMPERATURE HOUSING PV 4046 (K020587) _Pulsion Medical Systems AG · KRB · May 23, 2002 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/KRB/K020587 ## Device Facts - **Applicant:** Pulsion Medical Systems AG - **Product Code:** [KRB](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/KRB.md) - **Decision Date:** May 23, 2002 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1915 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The PULSION Pulsiocath Thermodilution Catheter and Pressure Monitoring Kit with Injectate In-Line Sensor are intended for use with the PULSION PiCCO Cardiac Output System for the measurement of cardiac output by the thermodilution method, measurement of arterial blood pressure, and for cardiac output determination by arterial pulse contour analysis. The PULSION PiCCO Cardiac Output System with Thermodilution Catheter and Pressure Monitoring Kit with Injectate In-Line Sensor is indicated in patients where cardiovascular and circulatory volume status monitoring is necessary. Such as patients in surgical, medical, cardiac, and burn specialty units as well as other specialty units where cardiovascular monitoring is desired and patients undergoing surgical interventions of such magnitude that cardiovascular monitoring is necessary. ## Device Story The PV4046 Injectate In-Line Sensor is a component of the Pulsion PiCCO Cardiac Output System. It functions as a thermodilution probe to measure injectate temperature. The system uses this input, alongside arterial blood pressure data, to calculate cardiac output via the thermodilution method and arterial pulse contour analysis. Used in clinical settings (surgical, medical, cardiac, burn units) by healthcare professionals to monitor hemodynamic status. The output provides real-time cardiovascular data to assist clinicians in managing patient volume status and cardiac function, potentially improving outcomes for critically ill or surgical patients. ## Clinical Evidence Bench testing only. Verification and validation activities included laboratory studies for performance, mechanical properties, and biocompatibility to establish safety and reliability. No clinical data was required. ## Technological Characteristics Injectate in-line sensor and housing (PV4046). Thermodilution probe sensing principle. Designed as a component of the Pulsion PiCCO Cardiac Output System. Modifications involve sensor design, materials, and dimensions. ## Regulatory Identification A thermodilution probe is a device that monitors cardiac output by use of thermodilution techniques; this device is commonly attached to a catheter that may have one or more probes. ## Predicate Devices - [K991886](/device/K991886.md) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ MAY 2 3 2002 ## 510(k) Summary KO20587 This summary of 510(k) safety and,effectiveness information is submitted in accordance with the requirements of the Safe Medical Devices Act of 1990 and 21 C.F.R. §807.92. | Submitter of this
premarket notification | Pulsion Medical Systems, AG
C/O James M. Delaney
EXPERTech Associates, Inc.
100 Main Street, Ste 120
Concord, MA 01742
Phone 978.371.0066
Fax 978.371.1676
e-mail: jdelaney@fdahelp.com | | |---------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------| | Date of summary | January 29, 2002 | | | Device name | Pulsion Pulsiocath PiCCO Monitoring Kit, Injectate Sensor Temperature
Housing PV 4046 | | | Common name | Injectate in-line sensor | | | Classification names | Regulation Number | Classification Name | | | §870.1915 | Probe, Thermodilution | | Predicate Devices | The modified device is substantially equivalent to the device previously
cleared under K991886. | | | Modifications | The primary modifications are changes to the injectate in-line sensor design,
materials, and dimensions. Corresponding dimensional changes have been
made to the housing to accommodate additional components and their
positioning within the housing resulting from the change. | | | Intended Use | The modified device has the same intended use as previously cleared in
K991886. The PV4046 injectate in-line sensor is a component of a
prescription use accessory package to the Pulsion PiCCO Cardiac Output
System. The accessory package was cleared with the following Indications
for Use:
The PULSION Pulsiocath Thermodilution Catheter and Pressure
Monitoring Kit with Injectate In-Line Sensor are intended for use with the
PULSION PiCCO Cardiac Output System for the measurement of cardiac
output by the thermodilution method, measurement of arterial blood
pressure, and for cardiac output determination by arterial pulse contour
analysis. The PULSION PiCCO Cardiac Output System with
Thermodilution Catheter and Pressure Monitoring Kit with Injectate In-Line
Sensor is indicated in patients where cardiovascular and circulatory volume
status monitoring is necessary. Such as patients in surgical, medical,
cardiac, and burn specialty units as well as other specialty units where
cardiovascular monitoring is desired and patients undergoing surgical | | {1}------------------------------------------------ KOZO587 p.2/2 interventions of such magnitude that cardiovascular monitoring is necessary. Technological characteristics Testing The modified device has the same technological characteristics as the legally marketed predicate devices. Verification and validation testing activities were conducted to establish the performance and reliability characteristics of the modified device. Testing involved safety testing from the risk analysis, including laboratory studies for performance, mechanical properties, and biocompatibility. Acceptance criteria were based on the specifications cleared for the predicate device and test results showed substantial equivalence. {2}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure. Public Health Service **MAY 23 2002** Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Pulsion Medical Systems, Inc. c/o Mr. James M. Delaney EXPERTECH Associates, Inc. 100 Main Street. Suite 120 Concord, MA 01742 Re: K020587 Pulsion Pulsiocath PiCCO Regulation Number: 870.1915 Regulation Name: Thermodilution Probe Regulatory Class: Class II (two) Product Code: 74 KRB Dated: February 19, 2002 Received: February 22, 2002 #### Dear Mr. Delaney: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act {3}------------------------------------------------ Page 2 - Mr. James M. Delaney comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Elias Mallis Image /page/3/Picture/6 description: The image contains a handwritten word that appears to be "for". The writing is cursive and the letters are connected. The "f" is a loop that extends above the other letters, and the "r" has a small curve at the end. Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ### 3.1 ODE Indications Statement ## Indications for. Use Statement | 510(k) Number
(if known) | K 02 0587 | |-----------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Device Name | The Pulsion PV4046 Injectate Sensor component of the
PULSION Pulsiocath Thermodilution Catheter and Pressure
Monitoring Kit with Injectate In-Line Sensor | | Indications for Use | The PULSION Pulsiocath Thermodilution Catheter and Pressure
Monitoring Kit with Injectate In-Line Sensor are intended for use
with the PULSION PiCCO Cardiac Output System for the
measurement of cardiac output by the thermodilution method,
measurement of arterial blood pressure, and for cardiac output
determination by arterial pulse contour analysis. The PULSION
PiCCO Cardiac Output System with Thermodilution Catheter and
Pressure Monitoring Kit with Injectate In-Line Sensor is indicated
in patients where cardiovascular and circulatory volume status
monitoring is necessary. Such as patients in surgical, medical,
cardiac, and burn specialty units as well as other specialty units
where cardiovascular monitoring is desired and patients
undergoing surgical interventions of such magnitude that
cardiovascular monitoring is necessary. | # PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Elias Mallis (Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number_KO20597 Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use 8 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/KRB/K020587](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/KRB/K020587) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com